LBG consultants have the insight, knowledge, and network to match your program with the appropriate government agency and/or opportunities, and employs a unique business model to help navigate the process.Learn More
LBG consultants have years of experience across all functional product development disciplines for vaccines, therapeutics, cell and gene therapies, and medical devices and diagnostics; and can provide on-demand expertise and advice at strategic crossroads or as a full-fledged product development team.Learn More
LBG consultants support pipeline and portfolio review and analysis, industry benchmarking, market research, asset opportunity and prioritization analysis, due diligence and financial modeling support among other things.Learn More
We provide the depth of expertise necessary to advance your programs, by offering a range of life science services supporting vaccine, therapeutic, medical device and diagnostic product development.
With proven expertise across a wide spectrum of life science products and sectors, LBG is equipped to deliver effective development and funding solutions for your specific needs. From vaccines to cell & gene therapies to diagnostics to animal health products, we have the depth of expertise to plug into your teams and provide the right guidance and support to help you reach your organizational objectives.
Product and sector expertise include:
- Cell & Gene Therapy
- Vaccine Development
- Therapeutic Products
- Non-Dilutive Funding
- Program Management
- Business Development
Robert Casillas, Ph.D., Managing Director, and Sarah Herring, Ph.D., Consultant, are attending the 15th Annual CounterACT Network Research Symposium in New Orleans on June 21 – 23. Dr. Casillas is …Read More
Peter Latham, Founding Partner, Mike McGinnis, Managing Partner, and several other team members are attending the BIO International Convention in San Diego on June 13 – 16. This year’s convention …Read More